Abstract
Fischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104-15. 35810756.
MeSH terms
-
Equivalence Trials as Topic
-
Functional Status
-
Humans
-
Ischemic Stroke* / drug therapy
-
Ischemic Stroke* / surgery
-
Randomized Controlled Trials as Topic
-
Thrombectomy
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
Substances
-
Tissue Plasminogen Activator